Group items tagged

Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a significant pace, owing to high unmet clinical need, limited survival benefits, growing prevalence rates and fast emerging treatment modifications.

The Global and Chinese Valsartan Industry, 2010-2020 Market Research Report is a professional and in-depth study on the current state of the global Valsartan industry with a focus on the Chinese market. The report provides key statistics on the market status of the Valsartan manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

2015 Global Retinoblastoma Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Retinoblastoma Drugs industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The EHV Cables industry development trends and marketing channels are analyzed.